Thésaurus cancer du poumon - GOThA (Groupe d'Oncologie ...

1. Zojwalla NJ, Raftopoulos H, Gralla RJ. Are cisplatine and carboplatine equivalent in the treatment of non-small cell lung
carcinoma? Results of a comprehensive review of randomized studies in over 2300 patients. Proc ASCO 2004;22:A7068.
2. Hotta K, Ueoka H, Kiura K. Meta-analys of randomised clinical trials comparing cisplatin to carboplatin in patients with
advanced non-small-cell lung cancer. JCO, 2004,22(19):3852-9
3. Oncologie thoracique : synthèse des connaissances et perspectives. A. Depierre et al. 221-229
4. Rosell R, Gomez-Codina J, Camps C et al. A randomized trial comparing preoperative chemotherapy plus surgery with
surgery alone in patients with non-small-cell lung cancer. N Engl J Med 1994; 330 : 153-8
5. Roth JA, Fossela F, Komaki R et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery
alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst 1994 ; 86 : 673-80
6. Depierre A, Milleron B, Moro-Sibilot D, et al. Preoperative chemotherapy followed by surgery compared with primary
surgery in resectable stage I (except TI N0), II, IIIA non-small-cell lung cancer. J Clin Oncol 2002 ; 20 : 247-53
7. Pignon JP, Stewart LA, Souhami RL et al. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell
lung cancer: a meta-analyse using updated data on individual patients from 52 randomized clinical trials. Br Med j
1995;311:899-909.
8. Scagliotti GV, Fossati R, Torri V, Crino L, Giaccone G, Silvano G, Martelli M, Clerici M, Cognetti F, Tonato M;
Adjuvant Lung Project Italy/European Organisation for Research Treatment of Cancer-Lung Cancer Cooperative Group
Investigators. Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell
Lung cancer. J Natl Cancer Inst. 2003 Oct 1;95(19):1453-61.
9. Arriagada R, Bergman B, Dunant A, Le Chevalier T, Pignon JP, Vansteenkiste J; International Adjuvant Lung Cancer
Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung
cancer. N Engl J Med. 2004 Jan 22;350(4):351-60.
10. Winton TL, Livingston, Johnson RD. A prospective randomised trial of adjuvant vinorelbine (VIN) and cisplatin (CIS) in
completely resected stage 1B and II non small cell lung cancer (NSCLC) Intergroup JBR.10. Proc ASCO 2004 ;22 :A7018.
11. Strauss GM, Herndon J, Maddaus MA. Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin
following resection in Stage IB non-small cell lung cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB)
Protocol 9633. Proc ASCO 2004;22:A7019.
12. Rosell, IASLC 2005, PR-3, S3
13. Kato H, Ichinose Y, Ohta M. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the
lung. N Engl J Med 2004;350:1713-1721.
14. Hamada C, Ohta M, Wada H. Survival benefit of oral UFT for adjuvant chemotherapy after completely resected nonsmall-cell
lung cancer. Proc ASCO 2004 ;22 :A7002.
15. Non-small Cell Lung Collaborative group. Chemotherapy in non-small cell lung cancer. A meta-analysis using updated data on
individual patients from 52 randomised clinical trials. BMJ 1995;311:899-909.
16. Cullen MH. Mitomycine,ifosfamide and cisplatine in unresectable -small cell lung cancer:effects on survival and quality of
life. J Clin Oncol 1999;17:188-94.
17. Stephens RJ. The Big Lung Trial : determinating the value of cisplatine-based chemotherapy for all patients with non-small
cell lung cancer.Preliminary results in the supportive care setting.Proc ASCO 2002;21:A1161.
18. Kelly K. randomized phase III trial of paclitaxel plus carboplatine versus vinorelbine plus cisplatine in the treatment of
patients with advanced non-small cell lung cancer: a southwest Oncology group trial. J Clin Oncol 2001;19:3210-8.
19. Schiller JH. Comparaison of four chemotherapy regimens for non-small cell lung cancer.
New Engl J Med 2002;346:92-8.
20. Scagliotti GV.Italian lung cancer project. Phase III randomized trial comparing three platinum-based doublets in advanced
non-small cell lung cancer. J Clin Oncol 2002;20:4285-91.
21. Fossela F. Randomized multinational, phase III study of docetaxel plus platinum combinaisons versus vinorelbine plus
platinum for advanced non-small cell lung cancer:the Tax 326 study group. J Clin Oncol 2003;21:3016-24.
22. Smit EF. EORTC,lung cancer group.Three-arm randomized study of two cisplatine-based regimens and paclitaxel plus
gemcitabine in advanced non-small cell lung cancer:a phase III trial of EORTC Lung cancer group 08975. J Clin Oncol
2003;21:3909-17.
23. Alberola V. Cispltine plus vinorelbine versus a cisplarine-bsed triplet versus non platinum sequential doublets in advanced
non-small cell lung cancer. J Clin Oncol 2003;21:3207-13.
24. Gridelli C. Gemcitabine plus vinorelbine compared with cisplatine plus vinorelbine or cisplatine plus gemcitabine for advanced
non-small cell lung cancer. J Clin Oncol 2003;21:3025-34.
25. Kosmidis P, Mylonakis N, Nicolaides C, Kalophonos C, Samantas E, Boukovinas J, Fountzilas G, Skarlos D,
Economopoulos T, Tsavdaridis D, Papakostas P, Bacoyiannis C, Dimopoulos M. Paclitaxel plus carboplatin versus
gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: a phase III randomized trial. J Clin Oncol. 2002 Sep
1;20(17):3578-85.
26. Smit EF, van Meerbeeck JP, Lianes P, Debruyne C, Legrand C, Schramel F, Smit H, Gaafar R, Biesma B, Manegold
C, Neymark N, Giaccone G; European Organization for Research and Treatment of Cancer Lung Cancer Group.Three-arm
randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a
phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group--EORTC 08975. J
Clin Oncol. 2003 Nov 1;21(21):3909-17.
27. Georgoulias V, Papadakis E, Alexopoulos A, Tsiafaki X, Rapti A, Veslemes M, Palamidas P, Vlachonikolis I; Greek
Oncology Cooperative Group (GOCG) for Lung Cancer. Related Articles, Links Platinum-based and non-platinum-based
chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial. Lancet. 2001 May 12;357(9267):1478-
84.
09/10/2006 52